Release Notes | MyRBQM® Portal Version 6.3.2
MyRBQM Portal V6.3.2 released! We're constantly working to improve your Risk-Based Quality Management experience. Download the summary of what has changed.
MyRBQM Portal V6.3.2 released! We're constantly working to improve your Risk-Based Quality Management experience. Download the summary of what has changed.
MyRBQM Portal V6.1.0 released! We're constantly working to improve your Risk-Based Quality Management experience. Download the summary of what has changed.
Cyntegrity developed a special COVID-19 RACT that guides those involved in clinical trials on specific risks which may arise as a result of COVID-19, and how they can mitigate them. This special RACT is part of the COVID-19 rapid deployment pack for ad-hoc centralized monitoring.
The need for a controlled research environment adds another risk dimension to the Phase 1 study design. The new Healthy Volunteers - Phase 1 RACT serves as a helpful source to ensure maximum subject safety and a reliable outcome.
MyRBQM Portal V6.0.8 has released! We're constantly working to improve your Risk-Based Quality Management experience, here's a summary of what has changed.
Heart Failure (HF) is a complex clinical syndrome. Our CSO, Dr Johann Proeve, explains the challenges associated with the conduct of clinical studies in the various heart failure stages.
MyRBQM Portal V6.0.6 has released! We're constantly working to improve your Risk-Based Quality Management experience, here's a summary of what has changed.
MyRBQM Portal is world's first one-stop clinical trial optimization solution and opens the door to fully fledged risk-based quality management. Get your free user license today!
Pharma today embraces the concept of patient-centered research. Innovators view Patients as informed collaborators whose participation is core to the overall success of clinical research. The risk-based Patient Profiles tool is a key contributor to the modern concept of patient-centered thinking, as It enables early detection and real time control of patient safety issues.
Many risks in clinical trials are therapy specific. Because of that, the currently available tools addressing those risks are now becoming therapy specific as well. The first therapy focused risk library Oncology RACT (OncoRACT) recently got available.